Legend Biotech (LEGN) Retained Earnings (2019 - 2025)
Legend Biotech (LEGN) posted Retained Earnings of $1.0 billion for Q4 2025, down 0.91% on a QoQ basis from $1.0 billion in Q3 2025, and down 3.7% year-over-year from $1.0 billion in Q4 2024.
Legend Biotech (LEGN) Retained Earnings (2019 - 2025) Analysis & Trends
Legend Biotech's Retained Earnings history runs 7 years deep, the most recent figure standing at $1.0 billion for Q4 2025.
- Quarterly Retained Earnings fell 3.7% year-over-year to $1.0 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 billion (down 3.7% YoY) and the FY2025 annual result came in at $1.0 billion, down 3.7% from the prior year.
- Retained Earnings was $1.0 billion for Q4 2025 at Legend Biotech, down from $1.0 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $1.4 billion in Q2 2023 and bottomed at $206424.0 in Q1 2021.
- A 5-year average of $858.3 million and a median of $1.0 billion in 2025 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings soared 358932.38% — and 2024, when it declined 17.63%.
- Legend Biotech's Retained Earnings stood at $766.0 million in 2021, then decreased by 2.87% to $744.0 million in 2022, then soared by 68.19% to $1.3 billion in 2023, then decreased by 16.85% to $1.0 billion in 2024, then declined by 3.7% to $1.0 billion in 2025.
- Business Quant data shows LEGN's Retained Earnings at $1.0 billion in Q4 2025, $1.0 billion in Q3 2025, and $1.0 billion in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -27.89 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -279.01 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 12.91 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -622,000.00 |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | 1.00 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.00 Bn |
| Sep 30, 2025 | 1.01 Bn |
| Jun 30, 2025 | 1.04 Bn |
| Mar 31, 2025 | 1.02 Bn |
| Dec 31, 2024 | 1.04 Bn |
| Sep 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | 1.16 Bn |
| Mar 31, 2024 | 1.16 Bn |
| Dec 31, 2023 | 1.25 Bn |
| Sep 30, 2023 | 1.34 Bn |
| Jun 30, 2023 | 1.41 Bn |
| Mar 31, 2023 | 653.12 Mn |
| Dec 31, 2022 | 744.00 Mn |
| Mar 31, 2022 | 741.13 Mn |
| Dec 31, 2021 | 766.00 Mn |
| Sep 30, 2021 | 225,837.00 |
| Jun 30, 2021 | 339,890.00 |
| Mar 31, 2021 | 206,424.00 |
| Dec 31, 2020 | 597.70 Mn |
| Dec 31, 2019 | 151.30 Mn |